The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era

Ижил төстэй зүйлс

• The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era
  -н: Camille C.B. Kockerols, зэрэг
  Хэвлэсэн: (2022-03-01)
• Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemia
  -н: Inge G.P. Geelen, зэрэг
  Хэвлэсэн: (2017-11-01)
• Impact of hospital experience on the quality of tyrosine kinase inhibitor response monitoring and consequence for chronic myeloid leukemia patient survival
  -н: Inge G.P. Geelen, зэрэг
  Хэвлэсэн: (2017-12-01)
• Impact of additional cytogenetic aberrations at diagnosis of chronic phase chronic myeloid leukemia
  -н: Fang Cheng, зэрэг
  Хэвлэсэн: (2025-09-01)
• Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations
  -н: Eva Ondroušková, зэрэг
  Хэвлэсэн: (2022-06-01)